New Class of Monoclonal Antibodies against Severe Influenza: Prophylactic and Therapeutic Efficacy in Ferrets

• Robert H. E. Friesen ,

  * E-mail: robert.friesen@crucell.com

  Affiliation Crucell Holland BV, Leiden, The Netherlands

  ⨯
• Wouter Koudstaal,

  Affiliation Crucell Holland BV, Leiden, The Netherlands

  ⨯
• Martin H. Koldijk,

  Affiliation Crucell Holland BV, Leiden, The Netherlands

  ⨯
• Gerrit Jan Weverling,

  Affiliation Crucell Holland BV, Leiden, The Netherlands

  ⨯
• Just P. J. Brakenhoff,

  Affiliation Crucell Holland BV, Leiden, The Netherlands

  ⨯
• Peter J. Lenting,

  Affiliation Crucell Holland BV, Leiden, The Netherlands

  ⨯
• Koert J. Stittelaar,

  Affiliation ViroClinics BV, Rotterdam, The Netherlands

  ⨯
• Albert D. M. E. Osterhaus,

  Affiliations ViroClinics BV, Rotterdam, The Netherlands, Department of Virology, Erasmus MC, Rotterdam, The Netherlands

  ⨯
• Ronald Kompier,

  Affiliation Crucell Holland BV, Leiden, The Netherlands

  ⨯
• Jaap Goudsmit

  Affiliation Crucell Holland BV, Leiden, The Netherlands

  ⨯